This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy used for the treatment of prostate cancer.
The contract has a ceiling value of $228,004.94 and a period of performance through February 28, 2025. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare agencies, including the VA, Department of Defense, and National Institutes of Health. The company holds several Indefinite Delivery Vehicles (IDVs) with the VA, ranging in value from approximately $1 million to $39.8 million, to provide ongoing deliveries of a variety of radiopharmaceuticals to VA medical facilities nationwide. This specific contract does not have a set-aside designation.
Generated 8/21/24, 7:35 PM